Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
J Gen Virol ; 89(Pt 3): 716-721, 2008 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-18272763

RESUMO

We have shown previously that a type-specific neutralization domain is located within a 39 aa sequence in the fourth variable domain of gp135 in visna/maedi virus. We now show that neutralizing antibodies detected early in infection are directed to this epitope, suggesting an immunodominant nature of this domain. Ten antigenic variants were previously analysed for mutations in this region, and all but one were found to be mutated. To assess the importance of these mutations in replication and neutralization, we reconstructed several of the mutations in an infectious molecular clone and tested the resulting viruses for neutralization phenotype and replication. Mutation of a conserved cysteine was shown to alter the neutralization epitope, whilst the replication kinetics in macrophages were unchanged. Mutations modulating potential glycosylation sites were found in seven of the ten antigenic variants. A frequently occurring mutation, removing a potential glycosylation site, had no effect on its own on the neutralization phenotype of the virus. However, adding an extra potential glycosylation site in the region resulted in antigenic escape. The results indicate that the conserved cysteine plays a role in the structure of the epitope and that glycosylation may shield the principal neutralization site.


Assuntos
Anticorpos Antivirais/imunologia , Cisteína/química , Mutação , Proteínas do Envelope Viral/genética , Proteínas do Envelope Viral/imunologia , Vírus Visna-Maedi/genética , Sequência de Aminoácidos , Animais , Anticorpos Antivirais/sangue , Linhagem Celular , Células Cultivadas , Plexo Corióideo/citologia , Plexo Corióideo/virologia , Glicosilação , Epitopos Imunodominantes/química , Epitopos Imunodominantes/genética , Epitopos Imunodominantes/imunologia , Dados de Sequência Molecular , Testes de Neutralização , Pneumonia Intersticial Progressiva dos Ovinos/imunologia , Pneumonia Intersticial Progressiva dos Ovinos/virologia , Ovinos , Proteínas do Envelope Viral/química , Proteínas do Envelope Viral/metabolismo , Vírus Visna-Maedi/imunologia
2.
J Virol ; 79(24): 15038-42, 2005 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-16306574

RESUMO

Maedi-visna virus (MVV) is a lentivirus of sheep sharing several key features with the primate lentiviruses. The virus causes slowly progressive diseases, mainly in the lungs and the central nervous system of sheep. Here, we investigate the molecular basis for the differential growth phenotypes of two MVV isolates. One of the isolates, KV1772, replicates well in a number of cell lines and is highly pathogenic in sheep. The second isolate, KS1, no longer grows on macrophages or causes disease. The two virus isolates differ by 129 nucleotide substitutions and two deletions of 3 and 15 nucleotides in the env gene. To determine the molecular nature of the lesions responsible for the restrictive growth phenotype, chimeric viruses were constructed and used to map the phenotype. An L120R mutation in the CA domain, together with a P205S mutation in Vif (but neither alone), could fully convert KV1772 to the restrictive growth phenotype. These results suggest a functional interaction between CA and Vif in MVV replication, a property that may relate to the innate antiretroviral defense mechanisms in sheep.


Assuntos
Produtos do Gene vif/fisiologia , Macrófagos/virologia , Vírus Visna-Maedi/fisiologia , Animais , DNA Viral/análise , Produtos do Gene vif/genética , Genoma Viral , Mutação , Ovinos , Doenças dos Ovinos/virologia , Replicação Viral , Vírus Visna-Maedi/patogenicidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA